Retrospective Assessment of the Clinical Pharmacist Sheets among a Few Iraqi General Hospitals
Abstract
Background: Clinical pharmacist sheet is an essential part of the medical record; it highlights the pharmacist’s role during hospitalisation through the concept of pharmaceutical care and specific pharmacist collaboration with a patient and other health care teams.
Objective: To assess the documentation completeness level of the clinical pharmacist sheet, pharmacist intervention, type and prevalence of Drug-Related Problems.
Methodology: A retrospective observational study that included revised 3900 clinical pharmacist sheets from Baghdad and Thiqar Hospitals for 2018, 2019, and 2020. The forms from four departments of the hospitals (internal medicine, surgery, paediatrics, gynaecology and obstetrics). In addition, assessment completeness of the pharmacist documentation level in the clinical pharmacist sheets, and Pharmacist interventions.
Results: The overall documentation completeness level in the clinical pharmacist sheets was generally poor (less than 50% of the sheet items were filled in). The best documentation level was presented in the surgery ward (52.34%). A total of 3900 clinical pharmacist sheets were analysed within multi-ward hospitals that revealed variable percentages of DRPs (10%, 8.55%, 12.44%, and 7.42%) in internal medicine, surgery, gynaecology and obstetrics, and paediatric respectively. Findings also revealed a significant decline in pharmacist interventions over the last three years.
Conclusion: There was poorn documentation completeness level and pharmacist interventions over the last 3 years among clinical pharmacist sheets. Drug selection, dosing, and substituting unavailable drugs with an alternative were the commonest causes of DRPs.
How to cite this article:
Abbas KM, Abdulridha MK. Retrospective Assessment of the Clinical Pharmacist Sheets among a Few Iraqi General Hospitals. J Commun Dis. 2021;53(4):61-69.
DOI: https://doi.org/10.24321/0019.5138.202175
References
Nissen L. Current status of pharmacist influences on prescribing of medicines. Am J Heal Pharm. 2009 Mar;66(5 Suppl 3):S29-34. [PubMed] [Google Scholar]
Elements P. ASHP Statement on Pharmaceutical Care. Medication therapy and patient care: organization and delivery of services statements. Best Pract. 2020:331-3.
Talasaz AH. The potential role of clinical pharmacy services in patients with cardiovascular diseases. J Tehran Univ Hear Cent. 2012 Spring;7(2):41-6. [PubMed] [Google Scholar]
Amir M. Clinical pharmacy practice: An activity based definition for pharmacy students of developing countries. Arch Pharm Pract. 2012;3(3):193. [Google Scholar]
Chillab RZ, Al-Sabbagh M, Fakhri H. Evaluation of pharmaceutical care application in Iraqi hospital. AJPS. 2009;6(1):18-31.[Google Scholar]
Baiz HQ, Aziz TA, Sharif DA. Potential effect of pharmaceutical care to improve outcomes in patients with chronic kidney disease-mineral bone disorder in Sulaimani dialysis centers. Al Mustansiriyah J Pharm Sci. 2020;20(1):82-94.[Google Scholar]
Runciman WB, Roughead EE, Semple SJ, Adams RJ. Adverse drug events and medication errors in Australia. Int J Qual Heal Care. 2003 Dec;15 Suppl 1:i49-59. [PubMed] [Google Scholar]
Ahmed B, Nanji K, Mujeeb R, Patel MJ. Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study. PLoS One. 2014 Nov;9(11):e112133. [PubMed] [Google Scholar]
Mallesh M, Reddy KP, Reddy PVN. Evaluation of the clinical pharmacist role in a health care team; a comparative approach. Indian J Pharm Pract. 2016;9(4):236-46.[Google Scholar]
World Health Organization. Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services. WHO Technical Report Series.2011;961:8-14.
Jokanovic N, Tan ECK, van den Bosch D, Kirkpatrick CM, Dooley MJ, Bell JS. Clinical medication review in Australia:a systematic review. Res Soc Adm Pharm. 2016 May-Jun;12(3):384-418. [PubMed] [Google Scholar]
Rouse MJ.Continuing professional development in pharmacy. Am J Heal Pharm. 2004;61:2069-76. [Google Scholar]
Barry AR, Pammett RT. Applying the guidelines for pharmacists integrating into primary care teams. Can Pharm J. 2016 Jul;149(4):219-25. [PubMed] [Google Scholar]
Dolovich L, Pottie K, Farrell B, Kaczorowski J, Sellors C, Gaebel K, Austin Z. The integrating family medicine and pharmacy to advance primary care therapeutics (IMPACT). ClinPharm J. 2004;137(1):22.[Google Scholar]
Lau HS, Florax Ch, Porsius AJ,DeBoer A. The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. Br J Pharmacol. 2000 Jun;49(6):597-603. [PubMed] [Google Scholar]
Kjeldsen LJ, Olesen C, Hansen MK, Nielsen TR. Clinical outcomes used in clinical pharmacy intervention studies in secondary care. Pharmacy (Basel). 2017 May;5(2):28. [PubMed] [Google Scholar]
Ufitinema Y, Wong R, Adomako E, Kanyamarere L, Ntagungira EK, Kagwiza J. Increasing patient medical record completion by assigning nurses to specific patients in maternity ward at Munini hospital.On the Horizon. 2000;24(4):327-34. [Google Scholar]
Tola K, Abebe H, Gebremariam Y, Jikamo B. Improving completeness of inpatient medical records in Menelik II Referral Hospital, Addis Ababa, Ethiopia. Adv Public Heal. 2017:1-5.[Google Scholar]
Lazzerini M, Tamburlini G. Hospital care for children : quality assessment and improvement tool. World Heal Organ. 2015;9(3):1.
Najim HD, Abdulridha MK, Abbas KM. Retrospective assessment of clinical pharmacist medication sheets documentation completeness from a sample of Iraqi health care units. 2020;20(2):228-41. [Google Scholar]
Khdour MR, Jarab AS, Adas HO, Samaro EZ, Mukattash TL, Hallak HO. Identification of drug-related problems: a prospective study in two general hospitals. Curr Clin Pharmacol. 2012 Nov;7(4):276-81. [PubMed] [Google Scholar]
ViktilKK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug related problems. Br J Clin Pharmacol.2007 Feb;63(2):187-95. [PubMed] [Google Scholar]
Silva C, Ramalho C, Luz I, Monteiro J, Fresco P. Drug-related problems in institutionalized, polymedicated elderly patients: opportunities for pharmacist intervention. Int J Clin Pharm.2015 Apr;37(2):327-34. [PubMed] [Google Scholar]
Lenssen R, Heidenreich A, Schulz JB,Fitzner T, Trautwein C, Jaehde U, Eisert A. Analysis of drug-related problems in three departments of a German University hospital. Int J Clin Pharm2015Feb;38(1):119-26. [PubMed] [Google Scholar]
Tully MP, Buchan IE. Prescribing errors during hospital inpatient care: factors influencing identification by pharmacists. Pharm World Sci 2009 Dec;31(6):682-8. [PubMed] [Google Scholar]
Mshiemish BA. Role of the clinical pharmacist in reducing preventable adverse drug events. Iraqi J Pharm Sci. 2011 Sep;20(2):85-90. [Google Scholar]
Bose NM, Mathew M, Joy B, Joel JJ, Rajesh KS, Raj KCB,Nandakumar UP. Assessment of drug related problems in the general medicine ward of a multispeciality teaching hospital. Int J Pharm Res. 2019Jul;11(3):52-60.
Yismaw MB, Adam H, Engidawork E. Identification and resolution of drug-related problems among childhood cancer patients in Ethiopia. J Oncol. 2020 Mar;2020:6785835. [PubMed] [Google Scholar]
Hohmann C, Eickhof C, Klotz JM, Schulz M, Radziwill R. Development of a classifcation system for drug-related problems in the hospital setting (APS-Doc) and assessment of the inter-rater reliability.J Clin Pharm Ther. 2012 Jun;37(3):276-81. [PubMed] [Google Scholar]
Taeqtmeyer AB, Kullak-Ublick GA, Widmer N, Falk V, Jetter A. Clinical usefulness of electronic drug-drug interaction checking in the care of cardiovascular surgery inpatients. Cardiology. 2012;123(4):219-22. [PubMed] [Google Scholar]
Mohammed S, Poudel S, Laloo F, Madhur A, Robert R, Mathew B. Assessment of drug-related problems in a tertiary care teaching hospital, India. Asian J Pharm Clin Res. 2017;10(2):310-3.
Tefera GM, Zeleke AZ, Jima YM, Kebede TM. Drug therapy problems and the role of clinical pharmacist in surgery ward: prospective observational and interventional study. Drug Healthc Patient Saf. 2020 May;12:71-83. [PubMed] [Google Scholar]
Saldanha V, Randall Martins R, Lima SIVC, Batista De Araujo I, Gouveia Oliveira A. Incidence, types and acceptability of pharmaceutical interventions about drug related problems in a general hospital: an open prospective cohort. BMJ Open. 2020 Apr;10(4):1-8. [PubMed] [Google Scholar]
Meng L, Qu C, Qin X, Huang H, Hu Y, Qiu F, Sun S. Drug-related problems among hospitalized surgical elderly patients in China. Biomed Res Int. 2021 Feb;2021:8830606. [PubMed] [Google Scholar]
Smedberg J, Brathen M, Waka MS, Jacobsen AF, Gjerdalen G, Nordeng H. Medication use and drug-related problems among women at maternity wards-a cross-sectional study from two Norwegian hospitals. Eur J Clin Pharmacol. 2016 Jul;72(7):849-57. [PubMed] [Google Scholar]
Thompson R, Whennan L, Liang J, Alderman C,Grzeskowiak LE. Investigating the frequency and nature of medication-related problems in the Women’s health unit of an Australian tertiary teaching hospital. Ann Pharmacother. 2015 Jul;49(7):770-6. [PubMed] [Google Scholar]
Ahmed SM, Sundby J,Aragaw YA, Nordeng H. Medication-related problems among hospitalized pregnant women in a tertiary teaching hospital in Ethiopia: a prospective observational study. BMC Pregnancy Childbirth. 2007 Nov;20(1):737. [PubMed] [Google Scholar]
Ku LC, Smith PB. Dosing in neonates: special considerations in physiology and trial design. Pediatr Res. 2015 Jan;77(1-1):2-9. [PubMed] [Google Scholar]
Rashed AN, Neubert A, Tomlin S, Jackman J, Alhamdan H, AlShaikh A, Attar A, Aseeri M, Wilton L, Wong IC. Epidemiology and potential associated risk factors of drug-related problems in hospitalised children in the United Kingdom and Saudi Arabia. Eur J Clin Pharmacol.2012 Dec;68(12):1657-66. [PubMed] [Google Scholar]
Jose B, Shareef J, Shenoy R. Assessment of drug related problems and pharmacist intervention in pediatric drug therapy in a tertiary care teaching hospital. Am J Pharm Tech Res. 2016;6(2):209-18.
Bedouch P, Charpiat B, Conort O, Rose FX, Escofier L, Juste M, Roubille R, Allenet. Assessment of clinical pharmacists’ interventions in French hospitals: results of a multicenter study. Ann Pharmacother. 2008 Jul;42(7-8):1095-103. [PubMed] [Google Scholar]
Birand N, Boşnak AS, Diker Ö, Abdikarim A, Başgut B. The role of the pharmacist in the multidisciplinary approach to the prevention and resolution of drug-related problems in cancer chemotherapy. J Oncol Pharm Pract. 2019 Sep;25(6):1312-20. [PubMed] [Google Scholar]
Cehajic I, Bergan S, Bjordal K. Pharmacist assessment of drug-related problems on an oncology ward. Eur J Hosp Pharm. 2015;22(4):194-7. [Google Scholar]
Basger BJ, Moles JR, Chen TF. Application of drug-related problem (DRP) classification systems: a review of the literature. Eur J Clin Pharmacol. 2014 Jul;70(7):799-815. [PubMed] [Google Scholar]
Ahjel SW, Al-Jumaili AA. The pharmacist’s missing role in the COVID-19 pandemic. Innov Pharm.2020 Apr;11(2):1-2. [PubMed] [Google Scholar]
Visacri MB, Figueiredo IV, Lima TM. Role of pharmacist during the COVID-19 pandemic: a scoping review. Res Social Adm Pharm. 2021 Jan;17(1):1799-806. [PubMed] [Google Scholar]
Bedouch P, Tessier A, Baudrant M, Labarere J, Foroni L, Calop J, Bosson JL, Allenet B. Computerized physician order entry system combined with on-ward pharmacist: analysis of pharmacists’ interventions. J Eval Clin Pract. 2012 Aug;18(4):911-8. [PubMed] [Google Scholar]
Falcão F, Viegas E, Lopes C, Branco R, Parrinha A, Alves ML, Leal F, Pina V, Madureira B, Cavaco P, Santos S, Carreira. Hospital pharmacist interventions in a central hospital. Eur J Hosp Pharm. 2015;22(2):94-7. [Google Scholar]
Zillich AJ, McDonough RP, Carter BL, Doucette WR. Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother. 2004 May;38(5):764-70. [PubMed] [Google Scholar]
Copyright (c) 2021 Author's
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
